Tech · Full coverage
Anthropic Negotiates $6 Billion Acquisition of Israeli AI Startup Decart
How 6 Israeli newsrooms covered this story — translated into English and compared side by side.
75% center
Center 3Right 1Unrated 2
First reported by Globes · 2 hours ago
What happened
Anthropic is negotiating to acquire Israeli AI startup Decart AI for about $6 billion, potentially its largest deal. Decart develops AI optimization technologies supported by Nvidia and recently raised $300 million at a $4 billion valuation. The acquisition aligns with Anthropic's IPO plans but remains in early stages.
- 01Anthropic is negotiating a $6 billion acquisition of Israeli AI startup Decart AI.
- 02Decart develops AI optimization tech improving chip efficiency and reducing training costs.
- 03Decart raised $300 million in May at a $4 billion valuation with investors including Nvidia and Adobe.
- 04Decart's technologies include real-time video editing and simulation models for robotics and autonomous driving.
- 05If acquired, Decart's team will join Anthropic's Inference and Performance division.
- 06The talks are preliminary and may not lead to a finalized deal.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 6 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
WallaCenter · Hebrew15 minutes ago
Anthropic Negotiates $6 Billion Acquisition of Israeli AI Startup Decart
Now 14Right · Hebrew35 minutes ago
Anthropic Negotiates $6 Billion Acquisition of Israeli AI Startup Decart AI
Related stories
Israeli AI Firm Decart Explores $5 Billion Acquisition Following Nvidia Funding3 days agoIsraeli Firm M.ai Gains Official Access to Anthropic's Advanced AI ModelsJul 1, 2026Anthropic Launches AI Drug Discovery Project Ahead of Major IPOJul 7, 2026Pentagon Cuts Ties with Anthropic Over AI Use DisputeJul 2, 2026Elon Musk Names Anthropic as Leading AI Model Amid Industry SurpriseJul 10, 2026Anthropic Launches AI Drug Discovery Initiative Amid Industry SkepticismJul 11, 2026